Piedmont Heart Institute Napa Valley Cardiology Conference
Avatar

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

By Piedmont Heart Institute Napa Valley Cardiology Conference FEATURING Thomas Deering
November 15, 2019
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
15:52
ARCH Advanced Revascularization Symposium

LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy

Feat. S. Yakubov
16:37
Cardiopulmonary Research Science and Technology Institute

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation

Feat. G. Stone
19:47
Complex Coronary Cases Symposium 2019

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Tr...

Feat. U. Baber
30:04
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Outpatient Management of Atrial Fibrillation

Feat. N. Olson
12:55
Cardiology Fiesta 2018

Heart Failure and Atrial Fibrillation – What Is the Right Approach for Y...

Feat. J. Pillarisetti
14:25
California Heart Rhythm Symposium

Therapies for Atrial Fibrillation in the Next Decade

Feat. H. Calkins
20:15
Cardiology Fiesta 2017

The Guidelines: Current Recommendations for TAVR, Left Atrial Appendage ...

Feat. S. Bailey
21:41
Cardiology Fiesta 2018

Results from the CABANA Trial: What Does it Mean

Feat. D. Packer
19:28
Northwestern Medicine: 7th Annual Cardiovascular Update

Re-Visiting the Natural History of AF: Who is at Risk of Stroke and What...

Feat. R. Passman
05:56
Cleveland Clinic Heart, Vascular and Thoracic Institute

Left Atrial Appendage Closure Device Implantation in Patients with Prior...

Feat. V. Menon
32:34
Cardiovascular Disease Management: A Case-Based Approach 2018

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A P...

Feat. J. Bunch
19:58
George Davis

Anticoagulant Reversal Agents

13:21
The North American Thrombosis Forum (NATF)

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to U...

Feat. C. Cruff
16:19
Jacqueline Saw

LAA Closure Devices for Stroke Prevention

14:53
Complex Interventional Cardiovascular Therapy (CICT) 2017

Tough Cases, Tough Calls: What Would You Do?

Feat. R. Quesada
17:08
Jonathan Piccini

Which Direct Acting Oral Anticoagulant for my Patient with Chronic Kidne...

30:13
Pediatric and Adult Interventional Cardiac Symposium

Cases: My Worst Nightmare Has Just Happened!

Feat. I. Kronzon, S. Goldstein, E. Salcedo, B. Khandheria
19:11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Rationale and Practical Aspects for using NOAC’s to Treat Afib and VTE

Feat. D. Blanchard